Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Capital Employed (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Capital Employed for 4 consecutive years, with 1.79% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed rose 24.0% to 1.79% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.79%, a 24.0% increase, with the full-year FY2024 number at 2.1%, down 110.0% from a year prior.
  • Return on Capital Employed was 1.79% for Q3 2025 at bioAffinity Technologies, up from 3.93% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.33% in Q4 2022 to a low of 3.93% in Q2 2025.
  • A 4-year average of 1.72% and a median of 1.52% in 2024 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was 24bps in 2025; the steepest drop was -237bps in 2025.
  • bioAffinity Technologies' Return on Capital Employed stood at 0.33% in 2022, then tumbled by -242bps to 1.15% in 2023, then crashed by -128bps to 2.61% in 2024, then soared by 31bps to 1.79% in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Return on Capital Employed are 1.79% (Q3 2025), 3.93% (Q2 2025), and 3.68% (Q1 2025).